Interleukin-1 Antagonism Decreases Cortisol Levels in Obese Individuals

Abstract

IL-1 antagonism in obese individuals with features of the metabolic syndrome leads to a decrease in serum cortisol, salivary cortisol, and ACTH levels along with a reduction in systolic blood pressure and heart rate.